MARINA I. MILLER, Ph.D., is an intellectual property (IP) attorney in the firm’s Chemical Patent Prosecution group focused on chemical, pharmaceutical and biotechnology patents. Her practice includes all phases of patent prosecution, including the preparation of patent applications, client counseling, providing patentability, invalidity and infringement opinions, and patent reexamination proceedings.
Dr. Miller has experience litigating pharmaceutical patents including abbreviated new drug application (ANDA) litigations, advising pioneering and generic pharmaceutical companies on U.S. Food and Drug Administration issues, and providing counseling and due diligence investigatory guidance. She has also evaluated IP issues that arise in corporate mergers and acquisitions and provided advice on building IP portfolios.
Prior to joining Oblon, Spivak, Dr. Miller served as a Patent Examiner with the United States Patent and Trademark Office (USPTO). She also was a law clerk and scientific advisor in the IP litigation department of a leading national law firm, with an emphasis on client counseling and litigation in matters involving pharmaceutical compounds, formulations, polymorphs, genetically engineered crops, and polymers.
Her industry experience includes working as a research scientist at the Center for Advanced Research in Biotechnology in Maryland, where she conducted structural studies of antigen recognition by T-cell receptors (TCRs) and T-cell activation by various superantigens. She was also a post-doctoral fellow at the Cornell Medical College at New York, where she researched the role of myosin-binding proteins in skeletal muscle and the heart. Dr. Miller is the author of 32 scientific publications and is named as an inventor on issued patents and pending patent applications.
Before attending law school, Dr. Miller received a Ph.D. in molecular biology/biochemistry from the All Union Research Institute of Genetics and Selection of Industrial Microorganisms in Moscow, Russia. Her thesis research focused on the discovery of a new approach for optimizing foreign gene expression in bacteria and expression and purification of different types of chemokines. Dr. Miller also has a master’s degree in physics from the Moscow Physics-Engineering Institute.
Dr. Miller is fluent in Russian.

